News from the FDA/CDC
News from the FDA/CDC
CDC panel backs COVID-19 boosters for nearly all adults
News from the FDA/CDC
FDA approves first CAR T-cell for adult ALL: For patients with R/R B-cell disease
“This is a meaningful advance because roughly half of all adults with B-ALL will relapse on currently available therapies.”
News from the FDA/CDC
Johnson & Johnson requests FDA approval for vaccine booster doses
The FDA’s independent vaccine advisory committee meets next week to review data on booster shots from both Johnson & Johnson and Moderna.
Latest News
CDC chief overrules panel, OKs boosters for health care workers
Panelists “did not buy the need in occupational or institutional settings.”
News from the FDA/CDC
COVID-19 claims more than 675,000 U.S. lives, surpassing the 1918 flu
In some ways, the United States has failed to learn from the mistakes of the past.
News from the FDA/CDC
Moderna vaccine more effective than Pfizer and J&J
“Understanding differences in [vaccine effectiveness] by vaccine product can guide individual choices and policy recommendations regarding vaccine...
News from the FDA/CDC
FDA grants zanubrutinib an accelerated approval in marginal zone lymphoma
News from the FDA/CDC
Even those who just test positive at more risk for long COVID: CDC
...
News from the FDA/CDC
EDs saw more benzodiazepine overdoses, but fewer patients overall, in 2020
Fentanyl became increasingly involved in benzodiazepine overdose deaths through the first half of the year.
News from the FDA/CDC
CDC panel unanimously backs Pfizer vax, fortifying FDA approval
The risk of myocarditis after a COVID infection was 6 to 34 times higher than the risk after receiving an mRNA vaccine.
News from the FDA/CDC
FDA fully approves Pfizer COVID-19 vaccine